MiR-484 promotes non-small-cell lung cancer (NSCLC) progression through inhibiting Apaf-1 associated with the suppression of apoptosis

Tao Li, Zongli Ding, Yulong Zheng, Wei Wang

Biomedicine & Pharmacotherapy · 2017 · 68 citations · 41 references

Concepts

References

41